Could cancer vaccine mark a turning point in preventing relapse?
From the Vigilantes take on criminal gangs in Haiti, and more of today's top videos series
A vaccine being developed by French company Transgene that is tailored to each individual patient using artificial intelligence could help prevent relapses, says the company. The 4050 vaccine has already been successfully tested on a sample of 16 patients with head and neck cancers and could theoretically be used to treat a variety of different cancers.
In this Series
As featured on
Vigilantes are taking the law into their own hands against gangs in Haiti, Brazil and Britai…
